News & Perspective

Jun 11, 2010

Jun 11, 2010

Serologic studies agree on seniors' partial protection from H1N1

(CIDRAP News) – In a bird's eye view of pandemic H1N1 seroprevalence studies published so far, the World Health Organization (WHO) said today the reports consistently show older people had partial protection and that infection rates were higher in younger people, but it's too soon to estimate a global attack rate.

May 07, 2010

May 07, 2010

Study: Adjuvanted H1N1 vaccine was very effective

(CIDRAP News) – A preliminary study from Germany suggests that an adjuvanted vaccine against the pandemic H1N1 virus was highly effective in adolescents and younger adults and moderately effective in older people, according to a report published yesterday in Eurosurveillance.

Mar 09, 2010

Mar 09, 2010

ECDC sees another pandemic wave as unlikely

(CIDRAP News) – European countries won't likely experience another wave of pandemic H1N1 influenza cases this spring and summer, though the virus will probably continue to circulate and be the region's dominant strain for the next flu season, the European Centre for Disease Prevention and Control (ECDC) said today.

Jan 25, 2010

Jan 25, 2010

WHO defends pandemic response ahead of Europe hearing

(CIDRAP News) – Just days before a Council of Europe hearing to discuss claims that pharmaceutical companies influenced the World Health Organization's (WHO's) pandemic response, the global body said charges by some European officials that the pandemic is "fake" are "wrong and irresponsible."

Jan 13, 2010

Jan 13, 2010

Health officials, experts reject 'false pandemic' charges

(CIDRAP News) – Leading public health officials and experts have sharply rejected charges from some European officials that pharmaceutical companies used exaggerated claims about the H1N1 pandemic threat to scare governments into buying unnecessary stockpiles of vaccines.

Sort Results

 

Narrow results

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M Gilead 
Grant support for ASP provided by

  Become an underwriter»